These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1878731)

  • 1. Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia.
    Gordon-Smith EC; Yandle A; Milne A; Speck B; Marmont A; Willemze R; Kolb H
    Bone Marrow Transplant; 1991; 7 Suppl 2():78-80. PubMed ID: 1878731
    [No Abstract]   [Full Text] [Related]  

  • 2. Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia: double-blind placebo controlled trial.
    Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
    Bone Marrow Transplant; 1991; 7 Suppl 2():85-6. PubMed ID: 1878735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
    Gorin NC; Coiffier B; Hayat M; Philip T; Vernant JP; Hervé P; Colombat P; Boivin P; Slavin S; Eugène-Jolchine I
    Bone Marrow Transplant; 1991; 7 Suppl 2():82. PubMed ID: 1878733
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin.
    Yau JC; Neidhart JA; Triozzi P; Verma S; Nemunaitis J; Quick DP; Mayernik DG; Oette DH; Haynes FA; Holcenberg J
    Am J Hematol; 1996 Apr; 51(4):289-95. PubMed ID: 8602629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of immunosuppressive therapy for aplastic anemia].
    Teramura M; Saito H; Kobayashi S; Hoshino S; Oshimi K; Mizoguchi H
    Rinsho Ketsueki; 1993 Mar; 34(3):273-6. PubMed ID: 7683063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia.
    Chap L; Schiller G; Nimer SD
    Bone Marrow Transplant; 1993 Aug; 12(2):173-5. PubMed ID: 8401368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.
    de Vries EG; Biesma B; Willemse PH; Mulder NH; Stern AC; Aalders JG; Vellenga E
    Cancer Res; 1991 Jan; 51(1):116-22. PubMed ID: 1988077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.
    De Witte T; Gratwohl A; Van der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
    Bone Marrow Transplant; 1991; 7 Suppl 2():83. PubMed ID: 1908729
    [No Abstract]   [Full Text] [Related]  

  • 13. New approach of treatment of severe aplastic anemia. Cooperative Group on the Treatment of Aplastic Anemia.
    Gluckman E; Bourdeau-Esperou H; Boogaerts M; Briere J; Navarro J; Leverger G; Leporrier M; Reiffers J; Janvier M; Michallet M
    Bone Marrow Transplant; 1991; 7 Suppl 2():106-7. PubMed ID: 1878666
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia.
    Locatelli F; Pedrazzoli P; Zecca M; Maccario R; Giorgiani G; Prete L; Nespoli L; Severi F
    Haematologica; 1991; 76(3):238-9. PubMed ID: 1743595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
    Ljungman P; Lawler M; Lönnqvist B; Ringdén O; Shanwell A
    Bone Marrow Transplant; 1996 Dec; 18(6):1179-81. PubMed ID: 8971392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of granulocyte-macrophage colony stimulating factor (GM-CSF) in cancer chemotherapy.
    Cebon JS; Morstyn G
    Cancer Surv; 1990; 9(1):131-55. PubMed ID: 2276111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
    Nemunaitis J; Rosenfeld CS; Ash R; Freedman MH; Deeg HJ; Appelbaum F; Singer JW; Flomenberg N; Dalton W; Elfenbein GJ
    Bone Marrow Transplant; 1995 Jun; 15(6):949-54. PubMed ID: 7581096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early trilineage recovery by granulocyte colony-stimulating factor in a patient with aplastic anemia.
    Hashimoto K; Kanakura Y; Yagura H; Mitsui H; Ogawa M; Horikawa Y; Nishiura T; Kanayama Y; Matsuzawa Y
    Acta Haematol; 1995; 93(2-4):110-2. PubMed ID: 7543718
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.